Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 5.25221059 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.25221059 |
3 | iron ion import (GO:0097286) | 4.84246578 |
4 | cellular response to ethanol (GO:0071361) | 4.49703622 |
5 | negative regulation of complement activation (GO:0045916) | 4.00107481 |
6 | negative regulation of protein activation cascade (GO:2000258) | 3.94969452 |
7 | nuclear pore complex assembly (GO:0051292) | 3.79788355 |
8 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.77601411 |
9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.76900030 |
10 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.70073451 |
11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.67101925 |
12 | COPII vesicle coating (GO:0048208) | 3.56981897 |
13 | positive regulation of nuclease activity (GO:0032075) | 3.54642022 |
14 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.46768672 |
15 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.36581694 |
16 | protein localization to endosome (GO:0036010) | 3.35829416 |
17 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.35205910 |
18 | vesicle coating (GO:0006901) | 3.33969622 |
19 | Golgi to endosome transport (GO:0006895) | 3.30201033 |
20 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.29169543 |
21 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.24788821 |
22 | protein retention in ER lumen (GO:0006621) | 3.19726876 |
23 | regulation of nuclease activity (GO:0032069) | 3.18036321 |
24 | nuclear pore organization (GO:0006999) | 3.17252859 |
25 | negative regulation of humoral immune response (GO:0002921) | 3.16305026 |
26 | early endosome to late endosome transport (GO:0045022) | 3.16081972 |
27 | ER-nucleus signaling pathway (GO:0006984) | 3.12371990 |
28 | cellular response to unfolded protein (GO:0034620) | 3.11739350 |
29 | intestinal cholesterol absorption (GO:0030299) | 3.07474941 |
30 | macroautophagy (GO:0016236) | 3.05599247 |
31 | protein targeting to vacuole (GO:0006623) | 2.98051229 |
32 | protein targeting to lysosome (GO:0006622) | 2.98051229 |
33 | establishment of protein localization to vacuole (GO:0072666) | 2.98051229 |
34 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.97251393 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95317912 |
36 | protein targeting to Golgi (GO:0000042) | 2.92896767 |
37 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91041186 |
38 | exocrine pancreas development (GO:0031017) | 2.89712224 |
39 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.88534336 |
40 | regulation of cholesterol homeostasis (GO:2000188) | 2.88443570 |
41 | endoplasmic reticulum organization (GO:0007029) | 2.85695615 |
42 | signal peptide processing (GO:0006465) | 2.84765807 |
43 | cellular response to topologically incorrect protein (GO:0035967) | 2.83077170 |
44 | 4-hydroxyproline metabolic process (GO:0019471) | 2.82503200 |
45 | positive regulation of macroautophagy (GO:0016239) | 2.81372206 |
46 | import into cell (GO:0098657) | 2.81146973 |
47 | establishment of protein localization to Golgi (GO:0072600) | 2.80625530 |
48 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.80330465 |
49 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.73823277 |
50 | response to endoplasmic reticulum stress (GO:0034976) | 2.71019330 |
51 | cysteine metabolic process (GO:0006534) | 2.70885868 |
52 | hepatocyte apoptotic process (GO:0097284) | 2.70005486 |
53 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.66686237 |
54 | regulation of complement activation (GO:0030449) | 2.66351023 |
55 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.65648881 |
56 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.65485449 |
57 | regulation of protein activation cascade (GO:2000257) | 2.64934017 |
58 | lysine catabolic process (GO:0006554) | 2.64606869 |
59 | lysine metabolic process (GO:0006553) | 2.64606869 |
60 | positive regulation of protein autophosphorylation (GO:0031954) | 2.63956552 |
61 | positive regulation of glycolytic process (GO:0045821) | 2.63323680 |
62 | growth hormone receptor signaling pathway (GO:0060396) | 2.60886872 |
63 | pore complex assembly (GO:0046931) | 2.60642506 |
64 | Golgi organization (GO:0007030) | 2.60285716 |
65 | detection of molecule of bacterial origin (GO:0032490) | 2.58103115 |
66 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.58086654 |
67 | regulation of Rac protein signal transduction (GO:0035020) | 2.57921955 |
68 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.57262032 |
69 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.56043385 |
70 | regulation of fibrinolysis (GO:0051917) | 2.55229338 |
71 | sulfur amino acid catabolic process (GO:0000098) | 2.54122516 |
72 | hormone catabolic process (GO:0042447) | 2.53259430 |
73 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.53007956 |
74 | L-serine transport (GO:0015825) | 2.52808108 |
75 | cellular glucuronidation (GO:0052695) | 2.52710395 |
76 | intestinal absorption (GO:0050892) | 2.52150191 |
77 | cellular extravasation (GO:0045123) | 2.50954482 |
78 | apoptotic cell clearance (GO:0043277) | 2.50093603 |
79 | cell adhesion mediated by integrin (GO:0033627) | 2.49770945 |
80 | negative regulation of fatty acid transport (GO:2000192) | 2.48323085 |
81 | hypotonic response (GO:0006971) | 2.47889636 |
82 | positive regulation of histone deacetylation (GO:0031065) | 2.46643134 |
83 | ER overload response (GO:0006983) | 2.45916783 |
84 | sequestering of metal ion (GO:0051238) | 2.45346775 |
85 | carnitine shuttle (GO:0006853) | 2.44785544 |
86 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.44134640 |
87 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.43770413 |
88 | carnitine transport (GO:0015879) | 2.42869520 |
89 | amino-acid betaine transport (GO:0015838) | 2.42869520 |
90 | mRNA modification (GO:0016556) | 2.41491932 |
91 | intracellular lipid transport (GO:0032365) | 2.41043579 |
92 | cellular response to growth hormone stimulus (GO:0071378) | 2.39998304 |
93 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.39565537 |
94 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.38779687 |
95 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.38229724 |
96 | negative regulation of hormone metabolic process (GO:0032351) | 2.37863984 |
97 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.35611480 |
98 | I-kappaB phosphorylation (GO:0007252) | 2.35497965 |
99 | definitive hemopoiesis (GO:0060216) | 2.35049415 |
100 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.33059943 |
101 | carnitine transmembrane transport (GO:1902603) | 2.33042175 |
102 | cellular zinc ion homeostasis (GO:0006882) | 2.32954342 |
103 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.32934053 |
104 | positive regulation of glycogen metabolic process (GO:0070875) | 2.32434613 |
105 | L-phenylalanine catabolic process (GO:0006559) | 2.32387707 |
106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32387707 |
107 | protein carboxylation (GO:0018214) | 2.32020328 |
108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.32020328 |
109 | cellular modified amino acid catabolic process (GO:0042219) | 2.31921523 |
110 | valine metabolic process (GO:0006573) | 2.30479550 |
111 | hippo signaling (GO:0035329) | 2.29813345 |
112 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.28723774 |
113 | hemidesmosome assembly (GO:0031581) | 2.28535695 |
114 | * response to unfolded protein (GO:0006986) | 2.28429022 |
115 | chondrocyte development (GO:0002063) | 2.27288992 |
116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.26479276 |
117 | membrane protein ectodomain proteolysis (GO:0006509) | 2.25234548 |
118 | zinc ion transport (GO:0006829) | 2.25097063 |
119 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.23932567 |
120 | negative regulation of fibrinolysis (GO:0051918) | 2.22756320 |
121 | intestinal epithelial cell development (GO:0060576) | 2.22463597 |
122 | positive regulation of p38MAPK cascade (GO:1900745) | 2.22194988 |
123 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.22037173 |
124 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.21754030 |
125 | glucuronate metabolic process (GO:0019585) | 2.21635649 |
126 | uronic acid metabolic process (GO:0006063) | 2.21635649 |
127 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.21333437 |
128 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.20684783 |
129 | mannose metabolic process (GO:0006013) | 2.20680940 |
130 | zinc ion transmembrane transport (GO:0071577) | 2.19974697 |
131 | regulation of beta-amyloid formation (GO:1902003) | 2.19672638 |
132 | negative regulation of lipid transport (GO:0032369) | 2.18312273 |
133 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.17889377 |
134 | receptor catabolic process (GO:0032801) | 2.17636640 |
135 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.17091825 |
136 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.15887789 |
137 | serine transport (GO:0032329) | 2.15422248 |
138 | Golgi to plasma membrane protein transport (GO:0043001) | 2.15114552 |
139 | positive regulation of muscle hypertrophy (GO:0014742) | 2.13969044 |
140 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.13969044 |
141 | desmosome organization (GO:0002934) | 2.13901262 |
142 | regulation of protein polyubiquitination (GO:1902914) | 2.13110393 |
143 | negative regulation of anoikis (GO:2000811) | 2.12609342 |
144 | phospholipid translocation (GO:0045332) | 2.12606478 |
145 | lipid translocation (GO:0034204) | 2.12606478 |
146 | type B pancreatic cell development (GO:0003323) | 2.12395934 |
147 | * response to topologically incorrect protein (GO:0035966) | 2.12059154 |
148 | phospholipid homeostasis (GO:0055091) | 2.11852006 |
149 | vesicle transport along microtubule (GO:0047496) | 2.11530811 |
150 | negative regulation of cell size (GO:0045792) | 2.10888546 |
151 | smooth muscle tissue development (GO:0048745) | 2.10837850 |
152 | collagen fibril organization (GO:0030199) | 2.10830044 |
153 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.10641227 |
154 | regulation of membrane lipid distribution (GO:0097035) | 2.10229024 |
155 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.09832174 |
156 | regulation of glucan biosynthetic process (GO:0010962) | 2.09610768 |
157 | regulation of glycogen biosynthetic process (GO:0005979) | 2.09610768 |
158 | N-glycan processing (GO:0006491) | 2.09385074 |
159 | glutamate metabolic process (GO:0006536) | 2.09299617 |
160 | skin morphogenesis (GO:0043589) | 2.09072383 |
161 | complement activation, alternative pathway (GO:0006957) | 2.08913054 |
162 | oligosaccharide catabolic process (GO:0009313) | 2.07230207 |
163 | labyrinthine layer development (GO:0060711) | 2.06823242 |
164 | homocysteine metabolic process (GO:0050667) | 2.06662933 |
165 | auditory receptor cell differentiation (GO:0042491) | 2.06645950 |
166 | low-density lipoprotein particle clearance (GO:0034383) | 2.05201555 |
167 | transcytosis (GO:0045056) | 2.04715750 |
168 | dorsal/ventral axis specification (GO:0009950) | 2.02648253 |
169 | regulation of ARF protein signal transduction (GO:0032012) | 2.02111871 |
170 | drug transmembrane transport (GO:0006855) | 2.01409927 |
171 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.01237063 |
172 | positive regulation of lipid catabolic process (GO:0050996) | 2.00847677 |
173 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.00673221 |
174 | midgut development (GO:0007494) | 2.00235857 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.63887538 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36953138 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.25308479 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83029303 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.63305623 |
6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60717920 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54106587 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52561232 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.41582358 |
10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14592262 |
11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.13848624 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.13399420 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.09603346 |
14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02450619 |
15 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.90560409 |
16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.84800848 |
17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80746439 |
18 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.75297238 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64226656 |
20 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63727357 |
21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63096448 |
22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61618687 |
23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61219900 |
24 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60843109 |
25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60700191 |
26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60686951 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.60633917 |
28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54850618 |
29 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52905202 |
30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52903610 |
31 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52681600 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52370748 |
33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.51465942 |
34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49114085 |
35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.47998279 |
36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46423360 |
37 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45788964 |
38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45628689 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44925332 |
40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43265584 |
41 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.43214117 |
42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42004234 |
43 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.41692964 |
44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41285927 |
45 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40550328 |
46 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.40236720 |
47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39816655 |
48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38899504 |
49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38514161 |
50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38147203 |
51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38019463 |
52 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.36439593 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36266064 |
54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36198740 |
55 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35829141 |
56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35829141 |
57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35070054 |
58 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.33419614 |
59 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.33188716 |
60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31751181 |
61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31359918 |
62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30902272 |
63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.30742410 |
64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30095963 |
65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29789935 |
66 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.29374758 |
67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29050005 |
68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29050005 |
69 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28924283 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28693581 |
71 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27937108 |
72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27759724 |
73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27497892 |
74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27466063 |
75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27236141 |
76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24537455 |
77 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.24431700 |
78 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24203210 |
79 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.24055974 |
80 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.23964179 |
81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22576289 |
82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20977018 |
83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20822395 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20320605 |
85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20041951 |
86 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19649121 |
87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19578802 |
88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19161316 |
89 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18628451 |
90 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.17869229 |
91 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17739545 |
92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17484617 |
93 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15033827 |
94 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14322836 |
95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14240437 |
96 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13948952 |
97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13571001 |
98 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13271277 |
99 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12999193 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12762227 |
101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12105890 |
102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11705874 |
103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10278176 |
104 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10239520 |
105 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10085917 |
106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09824373 |
107 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09303742 |
108 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08920186 |
109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08682237 |
110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08606738 |
111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08181950 |
112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08172329 |
113 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07482980 |
114 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07341252 |
115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06803317 |
116 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06151456 |
117 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06095971 |
118 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05759787 |
119 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05133820 |
120 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04846229 |
121 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04329952 |
122 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04308169 |
123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04206628 |
124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04205848 |
125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04205848 |
126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04032020 |
127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03963094 |
128 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.03731577 |
129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03293934 |
130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03208404 |
131 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01948341 |
132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01780190 |
133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01238352 |
134 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00851962 |
135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99661133 |
136 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99592713 |
137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99206815 |
138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99039417 |
139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98999313 |
140 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98287390 |
141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98064936 |
142 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98010070 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97707233 |
144 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96466191 |
145 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95083973 |
146 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94235703 |
147 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94123041 |
148 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.94004508 |
149 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92339026 |
150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91428138 |
151 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91290225 |
152 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90912123 |
153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90851985 |
154 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90525769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 4.20523779 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.69217977 |
3 | MP0009780_abnormal_chondrocyte_physiolo | 3.28540261 |
4 | MP0008438_abnormal_cutaneous_collagen | 3.19644532 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.14434034 |
6 | MP0005360_urolithiasis | 3.13963841 |
7 | MP0003300_gastrointestinal_ulcer | 3.12831414 |
8 | MP0005365_abnormal_bile_salt | 2.86734582 |
9 | MP0003252_abnormal_bile_duct | 2.77371833 |
10 | MP0001666_abnormal_nutrient_absorption | 2.55642958 |
11 | MP0006054_spinal_hemorrhage | 2.42809210 |
12 | MP0005085_abnormal_gallbladder_physiolo | 2.21693279 |
13 | MP0010352_gastrointestinal_tract_polyps | 2.20569969 |
14 | MP0004264_abnormal_extraembryonic_tissu | 2.10936374 |
15 | MP0002877_abnormal_melanocyte_morpholog | 2.03128794 |
16 | MP0003868_abnormal_feces_composition | 1.95169400 |
17 | MP0008057_abnormal_DNA_replication | 1.92399555 |
18 | MP0002896_abnormal_bone_mineralization | 1.91738804 |
19 | MP0000569_abnormal_digit_pigmentation | 1.87994377 |
20 | MP0005220_abnormal_exocrine_pancreas | 1.86491733 |
21 | MP0002909_abnormal_adrenal_gland | 1.83113447 |
22 | MP0003283_abnormal_digestive_organ | 1.80411737 |
23 | MP0005076_abnormal_cell_differentiation | 1.80408190 |
24 | MP0000013_abnormal_adipose_tissue | 1.79447358 |
25 | MP0005275_abnormal_skin_tensile | 1.73897061 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.63953902 |
27 | MP0002006_tumorigenesis | 1.63155662 |
28 | MP0000537_abnormal_urethra_morphology | 1.61712574 |
29 | MP0009384_cardiac_valve_regurgitation | 1.60217602 |
30 | MP0002396_abnormal_hematopoietic_system | 1.60062371 |
31 | MP0005187_abnormal_penis_morphology | 1.59021640 |
32 | MP0004134_abnormal_chest_morphology | 1.55799263 |
33 | MP0010329_abnormal_lipoprotein_level | 1.55238086 |
34 | MP0004185_abnormal_adipocyte_glucose | 1.49878246 |
35 | MP0003656_abnormal_erythrocyte_physiolo | 1.49565048 |
36 | MP0004272_abnormal_basement_membrane | 1.49409809 |
37 | MP0003566_abnormal_cell_adhesion | 1.47616804 |
38 | MP0003045_fibrosis | 1.47593359 |
39 | MP0001299_abnormal_eye_distance/ | 1.44822130 |
40 | MP0000003_abnormal_adipose_tissue | 1.44497050 |
41 | MP0005083_abnormal_biliary_tract | 1.44218183 |
42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43107921 |
43 | MP0000427_abnormal_hair_cycle | 1.42353667 |
44 | MP0010307_abnormal_tumor_latency | 1.36481504 |
45 | MP0001944_abnormal_pancreas_morphology | 1.35942353 |
46 | MP0005623_abnormal_meninges_morphology | 1.30844777 |
47 | MP0004043_abnormal_pH_regulation | 1.29360092 |
48 | MP0003091_abnormal_cell_migration | 1.28730237 |
49 | MP0010678_abnormal_skin_adnexa | 1.27540192 |
50 | MP0004130_abnormal_muscle_cell | 1.25755559 |
51 | MP0005164_abnormal_response_to | 1.23755236 |
52 | MP0003183_abnormal_peptide_metabolism | 1.21491171 |
53 | MP0009053_abnormal_anal_canal | 1.18603430 |
54 | MP0003172_abnormal_lysosome_physiology | 1.18314860 |
55 | MP0005248_abnormal_Harderian_gland | 1.18294640 |
56 | MP0003828_pulmonary_edema | 1.18243285 |
57 | MP0008961_abnormal_basal_metabolism | 1.17885249 |
58 | MP0004484_altered_response_of | 1.17127027 |
59 | MP0003866_abnormal_defecation | 1.14528886 |
60 | MP0005375_adipose_tissue_phenotype | 1.12641523 |
61 | MP0005503_abnormal_tendon_morphology | 1.09001297 |
62 | MP0003195_calcinosis | 1.08951881 |
63 | MP0000462_abnormal_digestive_system | 1.07944521 |
64 | MP0002166_altered_tumor_susceptibility | 1.05678421 |
65 | MP0000733_abnormal_muscle_development | 1.05161736 |
66 | MP0002928_abnormal_bile_duct | 1.04796103 |
67 | MP0002118_abnormal_lipid_homeostasis | 1.03830901 |
68 | MP0002078_abnormal_glucose_homeostasis | 1.03334910 |
69 | MP0000609_abnormal_liver_physiology | 1.03332387 |
70 | MP0001915_intracranial_hemorrhage | 1.02127802 |
71 | MP0004233_abnormal_muscle_weight | 1.00487504 |
72 | MP0002060_abnormal_skin_morphology | 1.00278018 |
73 | MP0002168_other_aberrant_phenotype | 0.99698247 |
74 | MP0005666_abnormal_adipose_tissue | 0.98569859 |
75 | MP0001958_emphysema | 0.98156030 |
76 | MP0005332_abnormal_amino_acid | 0.95791499 |
77 | MP0009643_abnormal_urine_homeostasis | 0.95451477 |
78 | MP0002693_abnormal_pancreas_physiology | 0.93303026 |
79 | MP0005451_abnormal_body_composition | 0.92195109 |
80 | MP0003724_increased_susceptibility_to | 0.90449151 |
81 | MP0005165_increased_susceptibility_to | 0.90421899 |
82 | MP0008775_abnormal_heart_ventricle | 0.89912742 |
83 | MP0005058_abnormal_lysosome_morphology | 0.89803262 |
84 | MP0004808_abnormal_hematopoietic_stem | 0.89728771 |
85 | MP0002090_abnormal_vision | 0.89005420 |
86 | MP0003303_peritoneal_inflammation | 0.88576686 |
87 | MP0004883_abnormal_blood_vessel | 0.87405099 |
88 | MP0005409_darkened_coat_color | 0.85963920 |
89 | MP0000465_gastrointestinal_hemorrhage | 0.84447305 |
90 | MP0004084_abnormal_cardiac_muscle | 0.84255709 |
91 | MP0002009_preneoplasia | 0.84151587 |
92 | MP0003943_abnormal_hepatobiliary_system | 0.84025059 |
93 | MP0008004_abnormal_stomach_pH | 0.83895066 |
94 | MP0001765_abnormal_ion_homeostasis | 0.83019081 |
95 | MP0004885_abnormal_endolymph | 0.82758134 |
96 | MP0000747_muscle_weakness | 0.80437600 |
97 | MP0001849_ear_inflammation | 0.79991318 |
98 | MP0001881_abnormal_mammary_gland | 0.75310670 |
99 | MP0005310_abnormal_salivary_gland | 0.75186213 |
100 | MP0002115_abnormal_skeleton_extremities | 0.72616823 |
101 | MP0010155_abnormal_intestine_physiology | 0.72256609 |
102 | MP0009703_decreased_birth_body | 0.72122312 |
103 | MP0003890_abnormal_embryonic-extraembry | 0.71533406 |
104 | MP0001661_extended_life_span | 0.71093888 |
105 | MP0002295_abnormal_pulmonary_circulatio | 0.70981807 |
106 | MP0002108_abnormal_muscle_morphology | 0.70603176 |
107 | MP0005621_abnormal_cell_physiology | 0.69711673 |
108 | MP0001756_abnormal_urination | 0.69699642 |
109 | MP0003279_aneurysm | 0.69499941 |
110 | MP0000534_abnormal_ureter_morphology | 0.69121244 |
111 | MP0005257_abnormal_intraocular_pressure | 0.69042449 |
112 | MP0001177_atelectasis | 0.68790631 |
113 | MP0000371_diluted_coat_color | 0.68699328 |
114 | MP0000604_amyloidosis | 0.68632727 |
115 | MP0004087_abnormal_muscle_fiber | 0.68318413 |
116 | MP0003795_abnormal_bone_structure | 0.67568755 |
117 | MP0003453_abnormal_keratinocyte_physiol | 0.66947807 |
118 | MP0001191_abnormal_skin_condition | 0.66666592 |
119 | MP0001879_abnormal_lymphatic_vessel | 0.66244336 |
120 | MP0003448_altered_tumor_morphology | 0.65354564 |
121 | MP0005408_hypopigmentation | 0.65241711 |
122 | MP0000428_abnormal_craniofacial_morphol | 0.65077508 |
123 | MP0002089_abnormal_postnatal_growth/wei | 0.64884272 |
124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63760941 |
125 | MP0003690_abnormal_glial_cell | 0.63703372 |
126 | MP0005367_renal/urinary_system_phenotyp | 0.63520181 |
127 | MP0000516_abnormal_urinary_system | 0.63520181 |
128 | MP0005023_abnormal_wound_healing | 0.63218312 |
129 | MP0000163_abnormal_cartilage_morphology | 0.63145787 |
130 | MP0002971_abnormal_brown_adipose | 0.62647665 |
131 | MP0009672_abnormal_birth_weight | 0.62520906 |
132 | MP0004036_abnormal_muscle_relaxation | 0.62305349 |
133 | MP0001835_abnormal_antigen_presentation | 0.61368702 |
134 | MP0004197_abnormal_fetal_growth/weight/ | 0.60475002 |
135 | MP0003950_abnormal_plasma_membrane | 0.60188456 |
136 | MP0003632_abnormal_nervous_system | 0.59133973 |
137 | MP0002876_abnormal_thyroid_physiology | 0.58893640 |
138 | MP0001243_abnormal_dermal_layer | 0.58624721 |
139 | MP0005319_abnormal_enzyme/_coenzyme | 0.58325420 |
140 | MP0000377_abnormal_hair_follicle | 0.58316401 |
141 | MP0000538_abnormal_urinary_bladder | 0.56424949 |
142 | MP0000767_abnormal_smooth_muscle | 0.56011116 |
143 | MP0005395_other_phenotype | 0.55746079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Osteolytic defects of the hand bones (HP:0009699) | 3.20539452 |
2 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.20539452 |
3 | Periodontitis (HP:0000704) | 3.07089045 |
4 | Subacute progressive viral hepatitis (HP:0006572) | 3.06740680 |
5 | Cardiovascular calcification (HP:0011915) | 3.04238118 |
6 | Asymmetry of the thorax (HP:0001555) | 3.00438877 |
7 | Curly hair (HP:0002212) | 2.97297639 |
8 | Cerebral aneurysm (HP:0004944) | 2.89724859 |
9 | Macroorchidism (HP:0000053) | 2.84904254 |
10 | Aortic aneurysm (HP:0004942) | 2.81280365 |
11 | Deep venous thrombosis (HP:0002625) | 2.78464838 |
12 | Absent frontal sinuses (HP:0002688) | 2.74774433 |
13 | Vascular calcification (HP:0004934) | 2.69179509 |
14 | Tetraparesis (HP:0002273) | 2.56977200 |
15 | Thyroid carcinoma (HP:0002890) | 2.49393054 |
16 | Mitral valve prolapse (HP:0001634) | 2.48311703 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43581815 |
18 | Aneurysm (HP:0002617) | 2.41338795 |
19 | Aortic dissection (HP:0002647) | 2.41094492 |
20 | Hypoglycemic coma (HP:0001325) | 2.40900367 |
21 | Protrusio acetabuli (HP:0003179) | 2.37491886 |
22 | Premature rupture of membranes (HP:0001788) | 2.36808863 |
23 | Shallow orbits (HP:0000586) | 2.36369240 |
24 | Intrahepatic cholestasis (HP:0001406) | 2.35642303 |
25 | Hypoplastic ischia (HP:0003175) | 2.34313085 |
26 | Abnormality of the ischium (HP:0003174) | 2.33550753 |
27 | Hypoglycemic seizures (HP:0002173) | 2.32125011 |
28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27856188 |
29 | Peritonitis (HP:0002586) | 2.26955041 |
30 | Abnormal foot bone ossification (HP:0010675) | 2.26918436 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25251504 |
32 | Fair hair (HP:0002286) | 2.24210725 |
33 | Hyperglycemia (HP:0003074) | 2.23768478 |
34 | Xanthomatosis (HP:0000991) | 2.20008942 |
35 | Abnormal biliary tract morphology (HP:0012440) | 2.19071640 |
36 | Back pain (HP:0003418) | 2.15611267 |
37 | Lymphangioma (HP:0100764) | 2.14685295 |
38 | Gingival bleeding (HP:0000225) | 2.13605992 |
39 | Hypobetalipoproteinemia (HP:0003563) | 2.13558341 |
40 | Turricephaly (HP:0000262) | 2.10334934 |
41 | Coarse hair (HP:0002208) | 2.09831340 |
42 | Ulnar bowing (HP:0003031) | 2.07244958 |
43 | Ketoacidosis (HP:0001993) | 2.06367683 |
44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.05004331 |
45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.05004331 |
46 | Mitral stenosis (HP:0001718) | 2.04947240 |
47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04470317 |
48 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.02135481 |
49 | Relative macrocephaly (HP:0004482) | 2.02041838 |
50 | Buphthalmos (HP:0000557) | 2.00732805 |
51 | Submucous cleft hard palate (HP:0000176) | 2.00476367 |
52 | Generalized hypopigmentation of hair (HP:0011358) | 1.99881329 |
53 | Abnormal tarsal ossification (HP:0008369) | 1.99301880 |
54 | Hematochezia (HP:0002573) | 1.97435304 |
55 | Cortical dysplasia (HP:0002539) | 1.96932595 |
56 | Skin nodule (HP:0200036) | 1.96307889 |
57 | Cervical subluxation (HP:0003308) | 1.94331153 |
58 | Deep philtrum (HP:0002002) | 1.94094799 |
59 | Epidermoid cyst (HP:0200040) | 1.93883229 |
60 | Enlarged penis (HP:0000040) | 1.93778092 |
61 | Fat malabsorption (HP:0002630) | 1.92609470 |
62 | Hepatoblastoma (HP:0002884) | 1.92325585 |
63 | Hypoplastic labia majora (HP:0000059) | 1.92301789 |
64 | Dilatation of the ascending aorta (HP:0005111) | 1.92015523 |
65 | Exostoses (HP:0100777) | 1.91214581 |
66 | Hamartoma of the eye (HP:0010568) | 1.91084909 |
67 | Termporal pattern (HP:0011008) | 1.90680125 |
68 | Insidious onset (HP:0003587) | 1.90680125 |
69 | Thin bony cortex (HP:0002753) | 1.88144971 |
70 | Bladder neoplasm (HP:0009725) | 1.88073580 |
71 | Bladder carcinoma (HP:0002862) | 1.88073580 |
72 | Resting tremor (HP:0002322) | 1.87283083 |
73 | Conjugated hyperbilirubinemia (HP:0002908) | 1.87035631 |
74 | Long toe (HP:0010511) | 1.87031747 |
75 | Gingivitis (HP:0000230) | 1.86913712 |
76 | Steatorrhea (HP:0002570) | 1.85216128 |
77 | Right ventricular cardiomyopathy (HP:0011663) | 1.85125280 |
78 | Ankyloglossia (HP:0010296) | 1.83075281 |
79 | Protuberant abdomen (HP:0001538) | 1.82787841 |
80 | Acute myeloid leukemia (HP:0004808) | 1.82146689 |
81 | Lower limb hyperreflexia (HP:0002395) | 1.81657437 |
82 | Tibial bowing (HP:0002982) | 1.81600846 |
83 | Eczematoid dermatitis (HP:0000976) | 1.81424079 |
84 | Wormian bones (HP:0002645) | 1.81242331 |
85 | Testicular neoplasm (HP:0010788) | 1.80848281 |
86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80139608 |
87 | Arterial tortuosity (HP:0005116) | 1.80003631 |
88 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79745096 |
89 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.79159962 |
90 | Rectal prolapse (HP:0002035) | 1.78419073 |
91 | Ketosis (HP:0001946) | 1.78281761 |
92 | Abnormality of the labia majora (HP:0012881) | 1.77538632 |
93 | Hyporeflexia of lower limbs (HP:0002600) | 1.77467856 |
94 | Increased CSF protein (HP:0002922) | 1.77241286 |
95 | Orthostatic hypotension (HP:0001278) | 1.76833302 |
96 | Ankle contracture (HP:0006466) | 1.75909365 |
97 | Epiphyseal dysplasia (HP:0002656) | 1.75868919 |
98 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.75798213 |
99 | Abnormal glucose tolerance (HP:0001952) | 1.75062827 |
100 | Hepatocellular carcinoma (HP:0001402) | 1.74739810 |
101 | Glucose intolerance (HP:0000833) | 1.74629423 |
102 | Mucopolysacchariduria (HP:0008155) | 1.74205073 |
103 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74205073 |
104 | Atrophic scars (HP:0001075) | 1.73855570 |
105 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.73621153 |
106 | Soft skin (HP:0000977) | 1.71075792 |
107 | Broad metatarsal (HP:0001783) | 1.70477343 |
108 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70261561 |
109 | Biliary tract neoplasm (HP:0100574) | 1.69260108 |
110 | Glomerulonephritis (HP:0000099) | 1.68993703 |
111 | Follicular hyperkeratosis (HP:0007502) | 1.68772968 |
112 | Spastic diplegia (HP:0001264) | 1.68596398 |
113 | Flat acetabular roof (HP:0003180) | 1.68329708 |
114 | Abdominal distention (HP:0003270) | 1.67146338 |
115 | Renal tubular acidosis (HP:0001947) | 1.65944900 |
116 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.65286409 |
117 | Vascular tortuosity (HP:0004948) | 1.64538022 |
118 | Myocardial infarction (HP:0001658) | 1.64217582 |
119 | Conjunctival hamartoma (HP:0100780) | 1.63684362 |
120 | Upper limb amyotrophy (HP:0009129) | 1.63658215 |
121 | Distal upper limb amyotrophy (HP:0007149) | 1.63658215 |
122 | Narrow palate (HP:0000189) | 1.63388022 |
123 | Severe short stature (HP:0003510) | 1.63224947 |
124 | Spondylolisthesis (HP:0003302) | 1.63019365 |
125 | Hypolipoproteinemia (HP:0010981) | 1.62063349 |
126 | Exocrine pancreatic insufficiency (HP:0001738) | 1.61982615 |
127 | Hand muscle atrophy (HP:0009130) | 1.61668205 |
128 | Hyperextensible skin (HP:0000974) | 1.61533867 |
129 | Symptomatic seizures (HP:0011145) | 1.60891874 |
130 | Cubitus valgus (HP:0002967) | 1.60473471 |
131 | Abnormality of oral frenula (HP:0000190) | 1.60347228 |
132 | Thoracolumbar scoliosis (HP:0002944) | 1.59766691 |
133 | Striae distensae (HP:0001065) | 1.58657817 |
134 | Overgrowth (HP:0001548) | 1.58616791 |
135 | Cystic hygroma (HP:0000476) | 1.58615835 |
136 | Overlapping toe (HP:0001845) | 1.58449765 |
137 | Spontaneous hematomas (HP:0007420) | 1.57954934 |
138 | Spinal cord lesions (HP:0100561) | 1.57763021 |
139 | Syringomyelia (HP:0003396) | 1.57763021 |
140 | Focal segmental glomerulosclerosis (HP:0000097) | 1.57226528 |
141 | Sandal gap (HP:0001852) | 1.57219267 |
142 | Complement deficiency (HP:0004431) | 1.57169802 |
143 | Blue irides (HP:0000635) | 1.57054375 |
144 | Infantile muscular hypotonia (HP:0008947) | 1.55825404 |
145 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.55571451 |
146 | Papilledema (HP:0001085) | 1.55450526 |
147 | Congenital glaucoma (HP:0001087) | 1.55321591 |
148 | Papillary thyroid carcinoma (HP:0002895) | 1.54953984 |
149 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.54549440 |
150 | Visceral angiomatosis (HP:0100761) | 1.53757285 |
151 | Bowel diverticulosis (HP:0005222) | 1.53508050 |
152 | Hypoalphalipoproteinemia (HP:0003233) | 1.53507737 |
153 | Small epiphyses (HP:0010585) | 1.53068083 |
154 | Cupped ribs (HP:0000887) | 1.52762114 |
155 | Vertebral clefting (HP:0008428) | 1.52501592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 4.06782097 |
2 | LATS1 | 3.29654582 |
3 | TRIB3 | 3.10740958 |
4 | ACVR1B | 2.73841441 |
5 | MAP3K10 | 2.57456388 |
6 | ERN1 | 2.56052900 |
7 | SIK1 | 2.55475905 |
8 | PKN2 | 2.48532852 |
9 | TAOK3 | 2.44736628 |
10 | ERBB3 | 2.38911052 |
11 | MAP3K2 | 2.33250969 |
12 | SCYL2 | 2.17006982 |
13 | RIPK1 | 2.05597095 |
14 | PTK6 | 2.02882924 |
15 | PDGFRA | 1.97737645 |
16 | INSRR | 1.96941061 |
17 | MAP3K14 | 1.84150247 |
18 | CASK | 1.78494364 |
19 | FGFR2 | 1.78075261 |
20 | BMPR2 | 1.72421982 |
21 | TTN | 1.67929509 |
22 | TYK2 | 1.60702735 |
23 | DDR2 | 1.59633484 |
24 | YES1 | 1.58148476 |
25 | SGK2 | 1.57340752 |
26 | EIF2AK3 | 1.57142148 |
27 | CAMK1D | 1.55793418 |
28 | CAMK1G | 1.55200263 |
29 | EEF2K | 1.50599103 |
30 | CAMKK2 | 1.46853219 |
31 | NLK | 1.45142682 |
32 | RET | 1.37776117 |
33 | STK3 | 1.28517948 |
34 | PAK3 | 1.23253889 |
35 | FER | 1.22407022 |
36 | MST4 | 1.21972528 |
37 | PDGFRB | 1.18481746 |
38 | EIF2AK1 | 1.15465868 |
39 | AKT3 | 1.14933542 |
40 | FGFR3 | 1.13254420 |
41 | MET | 1.11467242 |
42 | STK39 | 1.09126493 |
43 | LMTK2 | 1.08805193 |
44 | WNK1 | 1.08695989 |
45 | STK24 | 1.08347426 |
46 | MTOR | 1.08143490 |
47 | CDK12 | 1.07421045 |
48 | PTK2 | 1.05609726 |
49 | JAK1 | 1.05043408 |
50 | FGFR4 | 1.02444348 |
51 | BRSK2 | 1.00133481 |
52 | EPHB1 | 0.94271395 |
53 | PLK2 | 0.94248394 |
54 | NTRK1 | 0.93506535 |
55 | EPHA3 | 0.90843227 |
56 | MAP3K1 | 0.90295949 |
57 | PAK2 | 0.89960648 |
58 | MAP3K7 | 0.88978084 |
59 | KSR2 | 0.88559329 |
60 | WNK4 | 0.87857352 |
61 | PRKCH | 0.87794114 |
62 | CDK6 | 0.86589280 |
63 | DYRK1B | 0.86468915 |
64 | BMX | 0.85266583 |
65 | LRRK2 | 0.83877818 |
66 | MST1R | 0.83164590 |
67 | HIPK2 | 0.82791952 |
68 | TEC | 0.81951516 |
69 | PIK3CA | 0.81901772 |
70 | BCR | 0.79764016 |
71 | MAP3K13 | 0.79044760 |
72 | SGK3 | 0.78871501 |
73 | FGFR1 | 0.77933158 |
74 | BLK | 0.76231503 |
75 | BRD4 | 0.76163094 |
76 | NUAK1 | 0.75315948 |
77 | MAP3K4 | 0.74890321 |
78 | MAP3K12 | 0.74769253 |
79 | PNCK | 0.73273881 |
80 | PRKAA1 | 0.72733850 |
81 | DMPK | 0.72213997 |
82 | MAP2K1 | 0.70949726 |
83 | IRAK1 | 0.70629908 |
84 | ERBB4 | 0.67238183 |
85 | MAP2K3 | 0.66489125 |
86 | CAMKK1 | 0.64309924 |
87 | PTK2B | 0.64289397 |
88 | BCKDK | 0.63727464 |
89 | ZAP70 | 0.62226207 |
90 | GSK3A | 0.62148276 |
91 | MAP3K9 | 0.61620781 |
92 | RIPK4 | 0.60874348 |
93 | SGK494 | 0.60614148 |
94 | SGK223 | 0.60614148 |
95 | JAK2 | 0.60555446 |
96 | MAP2K4 | 0.60157149 |
97 | PAK6 | 0.59781075 |
98 | PRKD1 | 0.59416122 |
99 | PDPK1 | 0.59397996 |
100 | WNK3 | 0.59303585 |
101 | PDK2 | 0.59289261 |
102 | IRAK4 | 0.59168381 |
103 | STK38L | 0.59109923 |
104 | IRAK3 | 0.58550010 |
105 | FLT3 | 0.57905033 |
106 | MAP3K3 | 0.56245320 |
107 | PIK3CG | 0.55001347 |
108 | RAF1 | 0.54915638 |
109 | OXSR1 | 0.54045513 |
110 | RPS6KB1 | 0.53308263 |
111 | MAP3K6 | 0.53266977 |
112 | MELK | 0.52606235 |
113 | STK38 | 0.52043849 |
114 | ALK | 0.50922455 |
115 | PRKD3 | 0.50374642 |
116 | BMPR1B | 0.49995607 |
117 | GRK6 | 0.49833610 |
118 | EGFR | 0.49475620 |
119 | ERBB2 | 0.48062293 |
120 | KSR1 | 0.48046648 |
121 | JAK3 | 0.48025235 |
122 | CDC42BPA | 0.47259649 |
123 | CSNK1G2 | 0.46135292 |
124 | STK10 | 0.45906007 |
125 | LATS2 | 0.45702337 |
126 | CDK9 | 0.45459818 |
127 | CSNK1A1L | 0.44875973 |
128 | NEK6 | 0.44827389 |
129 | PDK1 | 0.44679649 |
130 | SGK1 | 0.44245267 |
131 | INSR | 0.43316648 |
132 | ROCK1 | 0.43126933 |
133 | PRKCE | 0.42533519 |
134 | CLK1 | 0.42467248 |
135 | CSNK1D | 0.41180701 |
136 | MKNK2 | 0.40253809 |
137 | PRKAA2 | 0.40234988 |
138 | MARK2 | 0.40166562 |
139 | STK4 | 0.38749270 |
140 | FYN | 0.38468464 |
141 | TRPM7 | 0.37796806 |
142 | TGFBR2 | 0.35532562 |
143 | STK11 | 0.35062887 |
144 | SIK3 | 0.34594239 |
145 | NEK9 | 0.34419456 |
146 | ICK | 0.34101567 |
147 | PDK3 | 0.33045137 |
148 | PDK4 | 0.33045137 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26391780 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.36978613 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86194342 |
4 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.72825272 |
5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.54613578 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52202784 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50145636 |
8 | Bile secretion_Homo sapiens_hsa04976 | 1.47073163 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44837748 |
10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43198148 |
11 | Circadian rhythm_Homo sapiens_hsa04710 | 1.34678223 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33836047 |
13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.33491076 |
14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27661340 |
15 | Insulin resistance_Homo sapiens_hsa04931 | 1.27588532 |
16 | Lysine degradation_Homo sapiens_hsa00310 | 1.23822391 |
17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23511602 |
18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22294373 |
19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.19033645 |
20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18209666 |
21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17180301 |
22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15968521 |
23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10945838 |
24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09274065 |
25 | Focal adhesion_Homo sapiens_hsa04510 | 1.08286648 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06632390 |
27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06294663 |
28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05827776 |
29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05419125 |
30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03596113 |
31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02353595 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.00640194 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00576698 |
34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99832071 |
35 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99153806 |
36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98247481 |
37 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97775842 |
38 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97743433 |
39 | Adherens junction_Homo sapiens_hsa04520 | 0.97096354 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96869656 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94511481 |
42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91370668 |
43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90747834 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90451022 |
45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90396952 |
46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89977721 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89870590 |
48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89747136 |
49 | Mineral absorption_Homo sapiens_hsa04978 | 0.89445149 |
50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86401520 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81189503 |
52 | ABC transporters_Homo sapiens_hsa02010 | 0.81119121 |
53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80959740 |
54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80856205 |
55 | Glioma_Homo sapiens_hsa05214 | 0.80780916 |
56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80673500 |
57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80515411 |
58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80257462 |
59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79402529 |
60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79375783 |
61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78510437 |
62 | Prostate cancer_Homo sapiens_hsa05215 | 0.78362026 |
63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78283720 |
64 | Amoebiasis_Homo sapiens_hsa05146 | 0.77904342 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77493052 |
66 | Protein export_Homo sapiens_hsa03060 | 0.77269660 |
67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76823601 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76216638 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75780238 |
70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74945058 |
71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73699140 |
72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73203705 |
73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72056350 |
74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70662767 |
75 | Hepatitis C_Homo sapiens_hsa05160 | 0.69053998 |
76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69028854 |
77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68523774 |
78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67898593 |
79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67750421 |
80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67626232 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67030678 |
82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66716519 |
83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66660371 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65990461 |
85 | Measles_Homo sapiens_hsa05162 | 0.64995257 |
86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63509754 |
87 | Hepatitis B_Homo sapiens_hsa05161 | 0.63293639 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62778147 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62751015 |
90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61690579 |
91 | Melanoma_Homo sapiens_hsa05218 | 0.61122409 |
92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60974998 |
93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60909143 |
94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60240128 |
95 | Renin secretion_Homo sapiens_hsa04924 | 0.59177906 |
96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58695222 |
97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58565942 |
98 | Legionellosis_Homo sapiens_hsa05134 | 0.58439850 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.58362357 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58299234 |
101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58225029 |
102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57912297 |
103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57780343 |
104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57140874 |
105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56296692 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56092083 |
107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55684753 |
108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54188033 |
109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53717499 |
110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53666699 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53480151 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53360104 |
113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53186889 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52349340 |
115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52300720 |
116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50919368 |
117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50263101 |
118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49885383 |
119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49623885 |
120 | Tight junction_Homo sapiens_hsa04530 | 0.49202588 |
121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49186881 |
122 | Lysosome_Homo sapiens_hsa04142 | 0.48429516 |
123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48315826 |
124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47361316 |
125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47318119 |
126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46512031 |
127 | Salivary secretion_Homo sapiens_hsa04970 | 0.46434260 |
128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46102138 |
129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45245918 |
130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44416465 |
131 | Prion diseases_Homo sapiens_hsa05020 | 0.43818413 |
132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43651588 |
133 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43446985 |
134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43302652 |
135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42058908 |
136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41833605 |
137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41715320 |
138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40727955 |
139 | Platelet activation_Homo sapiens_hsa04611 | 0.40717874 |